Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
---|
10/03/1991 | WO1991014438A1 Chimeric antibodies with receptor binding ligands in place of their constant region |
10/03/1991 | WO1991014424A1 Methods for protecting against chemotherapy-induced hair loss |
10/03/1991 | WO1991011462A3 Merosin, nucleic acids encoding, fragments and uses thereof |
10/03/1991 | CA2079233A1 Pharmaceutical formulations |
10/03/1991 | CA2078676A1 Use of il-4 to enhance immune response to infectious antigenic challenges |
10/03/1991 | CA2078131A1 Polypeptides useful in diagnosis of and treatment against mycoplasma infections in animals |
10/03/1991 | CA2075192A1 Insect retinoid receptor compositions and methods |
10/03/1991 | CA2057040A1 Induction of protection against viral infection by synergy between virus envelope glycoprotein and peptides corresponding to neutralization epitopes of the glycoprotein |
10/03/1991 | CA2039458A1 Methods for treating interleukin-1 mediated diseases |
10/03/1991 | CA2039259A1 Bispecific monoclonal antibodies, their production and use |
10/02/1991 | EP0449787A2 Pharmaceutical, dietetic or veterinary compositions with eumetabolic activity |
10/02/1991 | EP0449769A1 CD 25 binding molecules |
10/02/1991 | EP0449592A1 Bioelastomeric drug delivery system |
10/02/1991 | EP0449376A2 Production of enzymes in seeds and their use |
10/02/1991 | EP0449332A2 Glucosyltransferase inhibitors, as well as dental caries prevention methods and anticarious foods using the same |
10/02/1991 | EP0449170A1 Cellular binding protein with affinity for human type 18 papilloma virus regulatory region |
10/02/1991 | EP0449116A1 DNA sequences encoding modified retroviral gag polypeptides and vaccines containing them or aggregates thereof |
10/02/1991 | EP0449079A2 Hydantoin derivative |
10/02/1991 | EP0448940A2 Process for the preparation of mannosyl teicoplanin derivatives and mannosyl teicoplanin aglycone |
10/02/1991 | EP0448930A1 Stable compositions for parenteral administration and method of making same |
10/02/1991 | EP0448811A1 New pharmaceutical composition with anti-inflammatory activity |
10/02/1991 | EP0448770A1 Method for separating collagen |
10/02/1991 | EP0448704A1 Osteogenic devices |
10/02/1991 | EP0448688A1 N-acetylmuramidase m1 |
10/02/1991 | EP0448687A1 Therapeutic decapeptides |
10/02/1991 | EP0448677A1 Treatment of colon cancer |
10/02/1991 | EP0448652A1 Inhibitors of agonist-specific desensitization |
10/02/1991 | EP0448605A1 Use of basic amino acids to solubilize immunoglobulins |
10/02/1991 | EP0393140A4 Topical wound-healing preparations comprising interleukin-1 proteins |
10/02/1991 | EP0228458B1 Epithelial cells expressing foreign genetic material |
10/02/1991 | EP0217804B1 Analogs of substances p |
10/02/1991 | CN1055009A Production of human basic fgf-mutein |
10/02/1991 | CN1054900A Compositions and methods for treating infections caused by organisms sensitive to beta-lactam antibiotics |
10/01/1991 | WO1991015487A1 Novel 4h-3,1-benzoxazin-4-one derivative |
10/01/1991 | WO1991015223A1 Respiratory burst suppression factor |
10/01/1991 | US5053548 Biphenyl derivative composition for nerve cell degeneration repairing or protective agent and process for preparing a phenyl derivative contained in the composition |
10/01/1991 | US5053519 Hypotensive agents; diuretics; vasodilation |
10/01/1991 | US5053491 Stimulate hormonal secretion; highly specific imaging technique, radioactive labeling |
10/01/1991 | US5053490 Storage stability |
10/01/1991 | US5053453 Protein covalently bound to support material |
10/01/1991 | US5053424 2-(n-acyl)amino-6,7-dimethoxy tetralines, and pharmaceutical compositions having antihypertensive activity containing same |
10/01/1991 | US5053422 Learning-memory enhancers; nootropic agents |
10/01/1991 | US5053393 Novel platelet-aggregation inhibitor |
10/01/1991 | US5053392 Anticoagulants |
10/01/1991 | US5053391 Composition containing polypeptide hormone for stimulating skeletal growth in poultry |
10/01/1991 | US5053389 Insulin preparation for non-parenteral administration |
10/01/1991 | US5053388 Coating corneal incision with protein crosslinking compound, applying extra cellular matrix material, both with carriers |
10/01/1991 | US5053387 Feeding fish oil to reduce hypermetabolic state |
10/01/1991 | US5053386 Abrin and abrus agglutinin |
10/01/1991 | US5053337 Vectors, viruses, bacteriophage, plasmids, cells |
10/01/1991 | US5053334 Chinese hamster ovary; cross-flow filteration |
10/01/1991 | US5053226 Monoclonal antibodies binding platinum complexes |
10/01/1991 | US5053224 Induction of antibody response to solid tumors with anti-idiotype antibodies |
10/01/1991 | US5053216 Diagnosis,therapy of malignant tumors |
10/01/1991 | US5053005 Chemomodulation of curvature of the juvenile spine |
10/01/1991 | CA2056453A1 4h-3, 1-benzoxazin-4-one derivative |
10/01/1991 | CA2055593A1 Respiratory burst suppression factor |
10/01/1991 | CA2039359A1 Cellular binding protein having affinity for the regulatory region of the human papilloma virus type 18 |
10/01/1991 | CA2039341A1 Peptide derivatives |
10/01/1991 | CA2027447A1 Glycosaminoglycan-modified protein |
10/01/1991 | CA1290097C Peptide enzyme inhibitors |
10/01/1991 | CA1289880C Anti-human ovarian cancer immunotoxins and methods of use thereof |
09/30/1991 | CA2039231A1 Anti-oncostatin m monoclonal antibodies |
09/28/1991 | WO1991014452A1 Method for inhibiting cell growth and compositions useful therefor |
09/28/1991 | CA2081368A1 Method for inhibiting cell growth and compositions useful therefor |
09/27/1991 | WO1991014459A1 A bifunctional dtpa-type ligand |
09/27/1991 | WO1991014437A2 Use of copper(ii) containing compounds to accelerate wound healing |
09/25/1991 | EP0448356A2 Lipopeptide compounds |
09/25/1991 | EP0448355A2 Antibiotic agents |
09/25/1991 | EP0448354A2 Lipopeptide derivatives |
09/25/1991 | EP0448353A2 Lipopeptide compounds |
09/25/1991 | EP0448343A2 Lipopeptide derivatives |
09/25/1991 | EP0448301A2 Antibiotic agents |
09/25/1991 | EP0448299A2 Composition for increased skin concentration of active agents by iontophoresis |
09/25/1991 | EP0448181A2 Interleukin-6 inhibiting compositions |
09/25/1991 | EP0448146A1 Stabilized gonadotropin containing preparations |
09/25/1991 | EP0448099A2 Novel peptides |
09/25/1991 | EP0448075A1 Immunoglobulin G and process for the production thereof |
09/25/1991 | EP0448057A1 Monoclonal antibody reactive with a novel HLA determinant on MHC class I molecules and method for activating lymphocytes |
09/25/1991 | EP0447984A1 Hyperimmune globulin against hepatitis C virus and method for making same |
09/25/1991 | EP0447956A1 Plasmodium sporozoite antigen |
09/25/1991 | EP0447836A2 Amyloid peptide precursor RNA |
09/25/1991 | EP0447523A1 Compositions and methods for treating or preventing infections in canine and feline animals |
09/25/1991 | EP0447489A1 Human platelet-specific antibodies |
09/25/1991 | EP0447476A1 New tnf peptides |
09/25/1991 | EP0447474A1 New tnf peptides |
09/25/1991 | EP0447472A1 New tnf peptides |
09/25/1991 | EP0447465A1 New tnf peptides |
09/25/1991 | EP0447435A1 Novel tnf peptides |
09/25/1991 | EP0447432A1 New tnf peptides |
09/25/1991 | EP0447431A1 New tnf peptides |
09/25/1991 | EP0447430A1 New tnf peptides |
09/25/1991 | EP0447429A1 New tnf peptides |
09/25/1991 | EP0420964A4 Lyophilized peptide formulations |
09/25/1991 | EP0378671A4 Insulinomimetic and insulin receptor binding site peptides |
09/25/1991 | EP0311616B1 Combinations of gamma interferons and anti-inflammatory or anti-pyretic agents for treating diseases |
09/25/1991 | EP0118462B1 Stabilized gamma globulin concentrate |
09/25/1991 | CN1054773A Hemoregulatory peptides |
09/25/1991 | CN1054772A Synthetic polypeptides |
09/24/1991 | USRE33699 Polypeptides having norleucine, asparagine and aspartic acid groups to stimulate the release of Growth Hormone |